12 min listen
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
ratings:
Length:
5 minutes
Released:
Jun 30, 2022
Format:
Podcast episode
Description
David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.Read the full article:Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in EuropeContinue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Jun 30, 2022
Format:
Podcast episode
Titles in the series (100)
The Lancet Oncology: August 11, 2008 by The Lancet Oncology in conversation with